{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:32:33Z","timestamp":1789205553526,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/10527-3"],"award-info":[{"award-number":["2012\/10527-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funda\u00e7\u00e3o Zerbini","award":["2016\/24306-0"],"award-info":[{"award-number":["2016\/24306-0"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303573\/2015-5"],"award-info":[{"award-number":["303573\/2015-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.atherosclerosis.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T12:25:32Z","timestamp":1549974332000},"page":"100-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users"],"prefix":"10.1016","volume":"283","author":[{"given":"Francis Ribeiro de","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Rodrigues","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Armani","family":"Porello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Wesley Peixoto da","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luiza Carrari","family":"Sayegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Pinheiro","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Dias","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2594-8415","authenticated-orcid":false,"given":"Tiago Franco de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio","family":"Yonamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliam","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria Rodrigues","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo","family":"Negr\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Passarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo","family":"Rochitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3207-623X","authenticated-orcid":false,"given":"Maria Janieire de Nazar\u00e9 Nunes","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0002-9149(88)91390-2","article-title":"Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids","volume":"62","author":"McNutt","year":"1988","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00414-005-0055-9","article-title":"Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders","volume":"121","author":"Fineschi","year":"2007","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00421-014-2820-2","article-title":"Ventricular structure, function, and focal fibrosis in anabolic steroid users: a CMR study","volume":"114","author":"Angell","year":"2014","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib4","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","article-title":"Cardiovascular toxicity of illicit anabolic-androgenic steroid use","volume":"135","author":"Baggish","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3109\/10826084.2014.903751","article-title":"Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources","volume":"49","author":"Santos","year":"2014","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.steroids.2012.08.004","article-title":"Effects of anabolic androgenic steroids on chylomicron metabolism","volume":"77","author":"Morikawa","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1249\/MSS.0b013e3181c07b74","article-title":"Abnormal neurovascular control in anabolic androgenic steroids users","volume":"42","author":"Alves","year":"2010","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/sms.13332","article-title":"Retrograde and oscillatory shear rate in young anabolic androgenic steroid users","volume":"29","author":"Souza","year":"2019","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib10","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MAJ.0000000000000231","article-title":"High-density lipoprotein functionality in coronary artery disease","volume":"347","author":"Kosmas","year":"2014","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jat\/24.2.102","article-title":"Evaluation of testosterone\/epitestosterone ratio influential factors as determined in doping analysis","volume":"24","author":"van de Kerkhof","year":"2000","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10715768909073429","article-title":"Continuous monitoring of in vitro oxidation of human low density lipoprotein","volume":"6","author":"Esterbauer","year":"1989","journal-title":"Free Radic. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcct.2016.10.002","article-title":"SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of cardiovascular computed tomography guidelines committee: endorsed by the north American society for cardiovascular imaging (NASCI)","volume":"10","author":"Abbara","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib16","article-title":"Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study","volume":"4","author":"Castelli","year":"1988","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/2047487312437062","article-title":"Increased atherothrombotic markers and endothelial dysfunction in steroid users","volume":"20","author":"Severo","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1055\/s-0032-1331741","article-title":"Impaired post exercise heart rate recovery in anabolic steroid users","volume":"34","author":"dos Santos","year":"2013","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1559-4564.2006.05210.x","article-title":"Coronary calcification in body builders using anabolic steroids","volume":"9","author":"Santora","year":"2006","journal-title":"Prev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.atherosclerosis.2011.08.014","article-title":"Resistance training changes LDL metabolism in normolipidemic subjects: a study with a nanoemulsion mimetic of LDL","volume":"219","author":"da Silva","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib21","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1194\/jlr.P026005","article-title":"Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity","volume":"53","author":"Rubinow","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2019.02.006_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jacc.2009.02.068","article-title":"Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome","volume":"54","author":"Motoyama","year":"2009","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501930084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501930084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:37:20Z","timestamp":1758155840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501930084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":22,"alternative-id":["S002191501930084X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.02.006","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}